InvestorsHub Logo
Followers 276
Posts 32697
Boards Moderated 0
Alias Born 11/14/2013

Re: john1045 post# 64461

Wednesday, 06/15/2016 6:57:46 AM

Wednesday, June 15, 2016 6:57:46 AM

Post# of 699504
Thanks John!

The author intended and in fact caused the price of Cellceutix’s stock to decline. This type of manipulation of publicly traded stock is illegal and causes harm to companies and investors. We continue to work with regulators, prosecutors and law enforcement to assist in identifying the anonymous individuals and organizations intent on manipulating the value of a company’s stock by publishing dishonest articles in online forums, and other venues. Such ‘short and distort’ tactics are illegal, detrimental to our securities markets, and must stop.”

“We are extremely pleased with the ruling,” stated Leo Ehrlich, Chief Executive Officer of Cellceutix. “I greatly appreciate the work of the Ashcroft Law Firm. They never wavered in their support, and put forth a zealous defense of our Company against these baseless claims. Frivolous class action lawsuits are a huge burden on the biotech industry, negatively impacting shareholders and patients alike. Not only is a company materially damaged, but promising treatments and cures under development are put at greater risk of not making it to market. These actions caused significant damage to our Company and shareholders. We hope that the dismissal of this case and all its ramifications sends a powerful signal to others to think twice about pursuing such actions.” -- cellceutix.com/cellceutix-announces-dismissal-of-class-action-lawsuit-filed-by-rosen-law-firm/#sthash.99z9t6UB.dpbs


Respect Risk. Conduct Your Own Due Diligence. Manage your assets wisely. Diversify.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News